Comparison of the ribonucleotide with the canavanine reductase system.
D000594:Amino Acid Oxidoreductases / Q000037:antagonists & inhibitors*; D000818:Animals; D002172:Canavanine; D006528:Carcinoma, Hepatocellular; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D003545:Cysteine; D004112:Dimercaprol; D004229:Dithiothreitol; D004492:Edetic Acid; D005260:Female; D006898:Hydroxylamines; D006918:Hydroxyurea; D007501:Iron; D008113:Liver Neoplasms; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental; D010084:Oxidation-Reduction; D051381:Rats; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors; D013386:Succinates; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D008063:Thioctic Acid; D014168:Transferrin; D014184:Transplantation, Homologous
D006898:Hydroxylamines; D013386:Succinates; D013438:Sulfhydryl Compounds; D014168:Transferrin; D004112:Dimercaprol; D002172:Canavanine; D008063:Thioctic Acid; D004492:Edetic Acid; D007501:Iron; D012264:Ribonucleotide Reductases; D000594:Amino Acid Oxidoreductases; C019813:canavanine reductase; D003545:Cysteine; D004229:Dithiothreitol; D006918:Hydroxyurea